Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation

Irtiza N. Sheikh; Destiny Uwaezuoke; Olayinka Okeleji; Andres Quesada; Cynthia E. Herzog; Dristhi Ragoonanan; Priti Tewari; Demetrios Petropoulos; David McCall; Cesar Nunez; Michael Roth; Branko Cuglievan; Sajad Khazal

doi:10.1002/pbc.31489

Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation

Irtiza N. Sheikh, Destiny Uwaezuoke, Olayinka Okeleji, Andres Quesada, Cynthia E. Herzog, Dristhi Ragoonanan, Priti Tewari, Demetrios Petropoulos, David McCall, Cesar Nunez, Michael Roth, Branko Cuglievan, Sajad Khazal

Hematology/Oncology Division

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e31489
Journal	Pediatric Blood and Cancer
Volume	72
Issue number	3
DOIs	https://doi.org/10.1002/pbc.31489
State	Published - Mar 2025

ASJC Scopus Subject Areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.31489

OpenUrl availability

Full text

Cite this

Sheikh, I. N., Uwaezuoke, D., Okeleji, O., Quesada, A., Herzog, C. E., Ragoonanan, D., Tewari, P., Petropoulos, D., McCall, D., Nunez, C., Roth, M., Cuglievan, B., & Khazal, S. (2025). Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. Pediatric Blood and Cancer, 72(3), Article e31489. https://doi.org/10.1002/pbc.31489

Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. / Sheikh, Irtiza N.; Uwaezuoke, Destiny; Okeleji, Olayinka et al.
In: Pediatric Blood and Cancer, Vol. 72, No. 3, e31489, 03.2025.

Research output: Contribution to journal › Letter › peer-review

Sheikh, IN, Uwaezuoke, D, Okeleji, O, Quesada, A, Herzog, CE, Ragoonanan, D, Tewari, P, Petropoulos, D, McCall, D, Nunez, C, Roth, M, Cuglievan, B & Khazal, S 2025, 'Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation', Pediatric Blood and Cancer, vol. 72, no. 3, e31489. https://doi.org/10.1002/pbc.31489

@article{750f446c4cb84f06aa29ac382bb593fc,

title = "Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation",

author = "Sheikh, {Irtiza N.} and Destiny Uwaezuoke and Olayinka Okeleji and Andres Quesada and Herzog, {Cynthia E.} and Dristhi Ragoonanan and Priti Tewari and Demetrios Petropoulos and David McCall and Cesar Nunez and Michael Roth and Branko Cuglievan and Sajad Khazal",

year = "2025",

month = mar,

doi = "10.1002/pbc.31489",

language = "English",

volume = "72",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

number = "3",

}

TY - JOUR

T1 - Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation

AU - Sheikh, Irtiza N.

AU - Uwaezuoke, Destiny

AU - Okeleji, Olayinka

AU - Quesada, Andres

AU - Herzog, Cynthia E.

AU - Ragoonanan, Dristhi

AU - Tewari, Priti

AU - Petropoulos, Demetrios

AU - McCall, David

AU - Nunez, Cesar

AU - Roth, Michael

AU - Cuglievan, Branko

AU - Khazal, Sajad

PY - 2025/3

Y1 - 2025/3

UR - http://www.scopus.com/inward/record.url?scp=85212482236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85212482236&partnerID=8YFLogxK

U2 - 10.1002/pbc.31489

DO - 10.1002/pbc.31489

M3 - Letter

C2 - 39702892

AN - SCOPUS:85212482236

SN - 1545-5009

VL - 72

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 3

M1 - e31489

ER -

Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this